Mater Misericordiae Ltd | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures	brain disorder, central nervous system disorder, epilepsy, nervous system disorder	Recruiting	Phase 3	2026-10-08		NCT05667142
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Enrolling by invitation	Phase 3	2026-10-06		NCT04905693
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)	cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder	Recruiting	Phase 2	2026-09-25		NCT07318597
Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care	Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder	Recruiting	Phase 1 / Phase 2	2026-08-26		NCT07096934
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 2	2026-03-27		NCT06132256
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease	Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder	Recruiting	Phase 4	2026-01-15		NCT06257706